Management of Moderate to Severe Pain Completed Phase 1 Trials for Naltrexone (DB00704)

IndicationStatusPhase
DBCOND0056554 (Management of Moderate to Severe Pain)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01557257Pharmacokinetics Study of ALO-02 and OxyContinBasic Science